Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000487896 | SCV000529618 | likely benign | not provided | 2020-10-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000487896 | SCV000575146 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | CACNA1A: BP4, BP7 |
Ambry Genetics | RCV002318473 | SCV000851162 | likely benign | Inborn genetic diseases | 2016-08-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001079749 | SCV001029377 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV004999411 | SCV001143321 | benign | not specified | 2024-02-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000487896 | SCV001929733 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000487896 | SCV001969568 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000487896 | SCV002036600 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003985346 | SCV004726711 | likely benign | CACNA1A-related disorder | 2019-06-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |